A new postgraduate science degree is aiming to boost the next generation of drug discovery, from ‘concept to clinic.’
Launching in September 2013, the University of Nottingham’s one-year MSc in Drug Discovery and Pharmaceutical Sciences draws on world-leading expertise from the Schools of Pharmacy and Biomedical Sciences.
Designed to equip its students with an in-depth knowledge of all aspects of drug discovery, complemented by teaching in chemistry, biology and medicines regulation, the degree aims to develop well-rounded graduates with exceptional scientific understanding and a host of transferable skills critical for the global pharmaceutical industry.
The new programme comes at an important time for the pharmaceutical industry, as it seeks to streamline research and development activities alongside a more aggressive development of licensing new medicines from SMEs and education institutions. Students will gain important industrial experience working with companies to develop drugs to contribute to the global demand of new medicine development.
Professor Kevin Shakesheff, Head of the School of Pharmacy, University of Nottingham, said: "I am delighted that we are launching this masters degree in drug discovery and pharmaceutical sciences. At a time of significant change within the pharmaceutical industry, this cutting-edge programme will contribute to meeting the continuing and changing global employment needs of the pharma industry and provide an outstanding platform on which to build a future research career in new medicines design.”
Graduates from the degree can expect to move into a range of scientific careers, particularly with global pharmaceutical firms and SMEs. It will also provide a strong foundation for further research study at PhD-level.